Healthcare News
Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.
Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.
Study suggests new drug for weight loss may cause fewer side effects
A new Penn Nursing study suggests that the weight-loss drug tirzepatide may cause fewer side effects like nausea and vomiting than the drug semaglutide. This research, published in Science Advances, was conducted using preclinical models to study the effects of the drugs.
Pill form of semaglutide may be a suitable option for adults with overweight or obesity, trial suggests
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity.
Trying to Eat Less Meat? Try This Simple 30-Day Mediterranean Meal Plan, Created by a Dietitian
This 30-day plan is set at 1,800 calories per day, with modifications for 1,500 and 2,000 calories.